HUTCHMED

HCM

Market cap $2.29B

13.30 USD

-0.14

1.04%

At close Updated May 1, 4:00 PM EDT

Pre-market

After hours

13.30

0.00

1 day

-1.04%

5 days

-3.83%

1 month

-12.15%

3 months

-8.65%

6 months

-13.13%

Year to date

-2.56%

1 year

-10.14%

5 years

-52.5%

10 years

2.7%

About: HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Employees: 1,796

Healthcare Drug Manufacturers - Specialty & Generic